Discover Biostax Corp., a leading biotech development engine located in Orlando, FL. This innovative company specializes in powering efficient small-scale med-tech, pharmaceutical, and biotechnology programs. With a mission to revolutionize the health tech industry, Biostax Corp.

One of their notable programs is Lodonal, an approved treatment for HIV/AIDS in Nigeria. Lodonal is a one-day Immune System Regulator that has shown impressive results, with a 44% increase in CD4 Count compared to standard of care patients. It also reduces opportunistic infections, as demonstrated in several Phase II multi-center, randomized studies.

Another program is JKB-122, a small molecule and long-acting TLR4 antagonist. This drug exhibits anti-fibrotic, immuno-modulating, and anti-inflammatory activities, providing potential advancements in the treatment of liver injuries. BiostaxRx, their internal program, focuses on developing effective and affordable treatments for chronic inflammatory diseases.

They aim to improve patients' quality of life by safely reducing inflammation without compromising the immune system. In addition to these programs, Biostax Corp. With a commitment to innovation and improving patient outcomes, Biostax Corp